In vitro activity of ceftazidime-avibactam and comparators against bacterial isolates collected in South Korea as part of the ATLAS global surveillance program (2016-2018)
Citations

WEB OF SCIENCE

4
Citations

SCOPUS

3

초록

Overall, 1,277 Enterobacterales and 296 P. aeruginosa isolates were collected in South Korea between 2016 and 2018. Rates of susceptibility were >95% to ceftazidime-avibactam, tigecycline, meropenem and amikacin among the Enterobacterales and of the P. aeruginosa collected, 92.9% were susceptibility to amikacin and 92.6% to ceftazidime-avibactam. (c) 2021 The Authors. Published by Elsevier Inc. All rights reserved.

키워드

ATLASceftazidime-avibactamEnterobacteralesPseudomonas aeruginosaSouth Koreasurveillance
제목
In vitro activity of ceftazidime-avibactam and comparators against bacterial isolates collected in South Korea as part of the ATLAS global surveillance program (2016-2018)
저자
Bae, In-GyuStone, Gregory G.
DOI
10.1016/j.diagmicrobio.2021.115553
발행일
2022-01
유형
Article
저널명
Diagnostic Microbiology and Infectious Disease
102
1